Skip to main content
F

Formosa Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 6838 TW Professional, scientific and technical activities
Open in API
Filings indexed 23 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country TW Taiwan
Listing TW 6838

About Formosa Pharmaceuticals, Inc.

https://www.formosapharma.com

Formosa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company specializing in the development of innovative therapies within the fields of ophthalmology, oncology, and anti-infectives. The company utilizes its proprietary Activus Pure Nano-technology (APNT®) platform to enhance the formulation of poorly soluble drugs, improving bioavailability and efficacy. Its lead product, APP13007, is a clobetasol propionate ophthalmic suspension developed for the treatment of post-operative inflammation and pain following ocular surgery, which has received regulatory approval in the United States. Formosa Pharmaceuticals focuses on the 505(b)(2) regulatory pathway and the development of antibody-drug conjugates (ADCs). The company actively pursues global licensing and co-development partnerships to advance its pipeline of high-value therapeutic assets.

Recent filings

Filing Released Lang Actions
115年04月內部人持股異動(事後)
Regulatory Filings
2026-05-05 Chinese
115年04月董事會成員及持股
Regulatory Filings
2026-05-05 Chinese
115年4月背書保證與資金貸與
Regulatory Filings
2026-05-04 Chinese
115年4月營業收入
Regulatory Filings
2026-05-04 Chinese
115年年報及股東會資料 — 2026_6838_20260525F13.pdf
AGM Information Classification · 1% confidence The document is titled “115年股東常會各項議案參考資料” for Formosa Pharmaceuticals and contains detailed agenda items, reports, proposals, and reference materials for the Annual General Meeting (AGM). It is not a simple publication announcement but the full set of AGM materials provided to shareholders. Therefore, it fits the “AGM Information” category.
2026-04-27 Chinese
115年年報及股東會資料 — 2026_6838_20260525FE2.pdf
AGM Information Classification · 1% confidence The document is titled “2026 Annual General Shareholders’ Meeting Handbook” for Formosa Pharmaceuticals, Inc. It contains the meeting agenda, matters for report, ratification, discussion items, and attachments (business report, audit committee report, remuneration report, related party transactions, amendments to corporate governance documents, etc.) to be presented at the Annual General Meeting. This aligns precisely with AGM Information (materials shared during an AGM).
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.